Medtronic Plc

Medtronic Plc

MDT

Market Cap$100.11B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Medtronic PlcMedtronic Plc27.23.5%7%3.10.5

Earnings Call Q3 2024

February 20, 2024 - AI Summary

Medtronic reported solid Q3 results with revenue growth of 4.6% and adjusted EPS of $1.30, beating expectations.
The company saw strong performance in multiple businesses, including Core Spine, Cardiac Surgery, Structural Heart, and Cardiac Pacing.
Diabetes business showed double-digit growth, driven by the global adoption of the MiniMed 780G system. In the US, the business returned to growth, growing mid-single-digits.

Exclusive for Stockcircle Pro members

Sign upSign Up
$94.40

Target Price by Analysts

21.1% upsideMedtronic Plc Target Price DetailsTarget Price
$110.35

Current Fair Value

41.6% upside

Undervalued by 41.6% based on the discounted cash flow analysis.

Share Statistics

Market cap$100.11 Billion
Enterprise Value$117.13 Billion
Dividend Yield$2.7349 (3.5%)
Earnings per Share$2.76
Beta0.58
Outstanding Shares1,282,269,783
Avg 30 Day Volume6,383,102

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio27.23
PEG-61.19
Price to Sales3.12
Price to Book Ratio2.0
Enterprise Value to Revenue3.62
Enterprise Value to EBIT21.22
Enterprise Value to Net Income31
Total Debt to Enterprise0.21
Debt to Equity0.5

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Medtronic Plc

CEO: Geoffrey Martha